Can you speak to the efficacy of bimekizumab from the three pivotal head-to-head trials?
Featuring Mark Lebwohl, MD | Senior Clinical Advisor |
Dean for Clinical Therapeutics | Published October 20, 2023
Dean for Clinical Therapeutics
Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY